Healthcare

CLEARLAKE CAPITAL COMPLETES SALE OF TEAM TECHNOLOGIES

Sale to Arlington Capital Partners Completes Company's Transformation into a Healthcare-focused Specialized Manufacturing and Supply Chain Solutions Provider Under Clearlake…

2 months ago

Wellstack Partners With Hartford HealthCare to Advance Data Integration and Healthcare Analytics

Wellstack and Hartford HealthCare Partner to Drive Innovation in Data Integration and Patient-Centered Care MADISON, WILTZ / ACCESSWIRE / November…

2 months ago

Revitalist Releases Benefits Program Giving Access To All for Ketamine Therapies Changing the Narrative of Mental Health to Risk Mitigation

Vancouver, British Columbia--(Newsfile Corp. - November 25, 2024) - Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO)…

2 months ago

S4 Medical Receives FDA 510(k) Approval for its Redesigned Esophageal Deviation Device and Begins Commercialization

CHAGRIN FALLS, OH / ACCESSWIRE / November 25, 2024 / S4 Medical Corp, an Ohio based company committed to making…

2 months ago

Moderna to Present at Upcoming Conferences in December 2024

CAMBRIDGE, MA / ACCESSWIRE / November 25, 2024 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming…

2 months ago

Teladoc Health Expands AI Capabilities for Hospitals and Health Systems with Advanced Virtual Sitter Solution

New artificial intelligence (AI) capabilities help hospitals and health systems deliver safer and more efficient care Teladoc Health's AI-enabled Virtual…

2 months ago

MDxHealth to Participate in Piper Sandler Healthcare Conference

MDxHealth to Participate in Piper Sandler Healthcare Conference IRVINE, CA – November 25, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH)…

2 months ago

QHSLab, Inc. (OTCQB: USAQ) Marks Major Achievements in Digital Health Innovation, Research Recognition, and Revenue Growth in 2024

Revenue Growth and APA Recognition Drive Momentum for QHSLab in 2024 WEST PALM BEACH, FL, Nov. 25, 2024 (GLOBE NEWSWIRE)…

2 months ago

Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China

ST. LOUIS and SHANGHAI, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Shanghai MicroPort EP Medtech Co., Ltd.…

2 months ago

IMUNON Announces Results from its End-of-Phase 2 Meeting with the FDA for its Lead IMNN-001 Clinical Program in Advanced Ovarian Cancer

FDA Project Team supports the company’s proposed Phase 3 trial strategy, including overall trial design, target patient population, treatment schedule,…

2 months ago